Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -267.04%-8.28M | -86.40%-65.26M | 19.28%-2.26M | -58.41%-35.01M | -242.80%-2.8M | 3.69%-22.1M | 135.29%1.96M | -298.39%-22.95M | 55.08%-5.55M | -29.42%11.57M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 56.01%-348K | ---- | -82.68%-791K | ---- | -50.87%-433K | ---- | ---287K | ---- | ---- |
| Investment loss (gain) | 1.12%-265K | -6.82%-47K | -28.23%-268K | 68.35%-44K | 44.27%-209K | 43.50%-139K | 6.02%-375K | 51.57%-246K | -166.00%-399K | 14.62%-508K |
| Attributable subsidiary (profit) loss | 57.50%63K | -95.63%76K | -50.62%40K | 967.48%1.74M | -54.49%81K | 7.24%163K | --178K | --152K | ---- | ---- |
| Impairment and provisions: | -100.32%-43K | 368.19%60.32M | 44,013.33%13.23M | 102.01%12.88M | 57.89%30K | 979.19%6.38M | -92.58%19K | -3.43%591K | -64.35%256K | 856.25%612K |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --53K |
| -Impairmen of inventory (reversal) | ---- | -200.00%-146K | ---74K | --146K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | -248.28%-43K | 220.69%93K | -3.33%29K | 123.08%29K | 57.89%30K | -97.80%13K | -92.58%19K | 354.62%591K | 8.94%256K | 103.13%130K |
| -Impairment of goodwill | ---- | 223.83%38.67M | ---- | 87.62%11.94M | ---- | --6.37M | ---- | ---- | ---- | --429K |
| -Other impairments and provisions | ---- | 2,729.60%21.7M | --13.28M | --767K | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -158.53%-18.44M | ---9.04M | -84.26%-7.13M | ---- | ---3.87M | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | -158.53%-18.44M | ---9.04M | -84.26%-7.13M | ---- | ---3.87M | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | 66.40%-128K | 895.48%1.23M | -19,150.00%-381K | -569.70%-155K | --2K | -89.97%33K | ---- | 1,631.58%329K | 260.00%18K | 114.50%19K |
| -Loss (gain) from sale of subsidiary company | ---- | --740K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -21.10%86K | 418.06%493K | 5,350.00%109K | -569.70%-155K | --2K | -89.97%33K | ---- | 1,631.58%329K | 260.00%18K | 114.50%19K |
| -Loss (gain) from selling other assets | 56.33%-214K | ---- | ---490K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | -17.65%11.82M | -3.88%28.16M | 12.63%14.35M | 26.31%29.3M | 16.33%12.74M | 59.64%23.19M | 63.64%10.95M | 9.00%14.53M | 1.50%6.69M | 13.40%13.33M |
| -Amortization of intangible assets | -43.71%1.71M | -23.09%5.13M | 70.85%3.04M | 88.34%6.67M | 0.28%1.78M | 239.18%3.54M | 556.30%1.77M | 807.83%1.04M | 671.43%270K | 71.64%115K |
| Financial expense | -11.35%1.4M | 0.29%2.81M | 20.38%1.58M | -0.11%2.8M | -18.73%1.31M | 15.79%2.8M | 50.94%1.61M | -0.94%2.42M | -11.59%1.07M | 4.54%2.44M |
| Exchange Loss (gain) | 108.73%11K | 78.10%-201K | 79.71%-126K | 67.10%-918K | 59.20%-621K | -244.11%-2.79M | -244.54%-1.52M | 491.11%1.94M | 21,160.00%1.05M | -12,275.00%-495K |
| Special items | -61.97%1.41M | 62.62%7.31M | 54.69%3.71M | 69.96%4.49M | 46.16%2.4M | 154.62%2.64M | --1.64M | 128.83%1.04M | ---- | ---3.6M |
| Operating profit before the change of operating capital | -71.30%5.98M | 118.03%15.61M | 61.09%20.84M | 21.81%7.16M | -10.56%12.94M | 336.25%5.88M | 360.49%14.46M | -110.65%-2.49M | 154.12%3.14M | -21.63%23.36M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 16,008.33%5.73M | -343.74%-2.79M | -104.37%-36K | 123.68%1.14M | -80.60%823K | 616.16%511K | 220.89%4.24M | 97.34%-99K | ---3.51M | ---3.73M |
| Accounts receivable (increase)decrease | 117.11%827K | -10.83%-4.05M | -21.95%-4.83M | -1,459.11%-3.66M | -260.27%-3.96M | -72.41%269K | -191.29%-1.1M | -69.83%975K | -58.80%1.21M | 200.72%3.23M |
| Accounts payable increase (decrease) | -284.95%-1.55M | 313.75%9.12M | -17.70%837K | 213.85%2.2M | 154.53%1.02M | 71.13%-1.94M | 71.33%-1.87M | -419.04%-6.7M | -2,431.52%-6.51M | -31.92%2.1M |
| prepayments (increase)decrease | 116.08%3.78M | -1,740.21%-28.38M | -592.84%-23.52M | 78.60%-1.54M | 58.98%-3.39M | -427.55%-7.21M | 31.49%-8.27M | 143.65%2.2M | -213.93%-12.08M | 1.31%-5.04M |
| Special items for working capital changes | -155.66%-4.87M | 384.70%16.95M | 2,227.13%8.75M | 736.60%3.5M | 104.85%376K | -93.94%418K | -256.37%-7.76M | 236.09%6.9M | 159.65%4.96M | -17.15%2.05M |
| Cash from business operations | 384.48%9.9M | -26.61%6.46M | -73.79%2.04M | 526.39%8.81M | 2,769.86%7.8M | -363.06%-2.07M | 97.72%-292K | -96.43%785K | -152.05%-12.78M | -18.76%21.98M |
| Other taxs | ---3.57M | 41.98%-456K | ---- | -274.29%-786K | -701.98%-810K | 93.54%-210K | 96.67%-101K | 58.45%-3.25M | 27.24%-3.03M | 22.36%-7.83M |
| Net cash from operations | 209.69%6.33M | -25.10%6.01M | -70.76%2.04M | 452.48%8.02M | 1,877.61%6.99M | 7.75%-2.28M | 97.52%-393K | -117.42%-2.47M | -71.20%-15.82M | -16.62%14.16M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -79.23%27K | -66.04%254K | -35.96%130K | 72.75%748K | -33.00%203K | 50.87%433K | 30.60%303K | --287K | --232K | ---- |
| Decrease in deposits (increase) | ---- | 119.02%23.59M | 31,982.43%23.59M | -42.82%10.77M | -100.20%-74K | 148.05%18.84M | 235.71%37.7M | -152.93%-39.2M | -164.60%-27.78M | ---15.5M |
| Sale of fixed assets | --243K | -88.33%37K | ---- | --317K | --38K | ---- | ---- | 1,620.00%86K | --107K | -97.88%5K |
| Purchase of fixed assets | 66.93%-1.42M | 51.98%-8.64M | 47.34%-4.3M | 4.53%-18M | 4.50%-8.17M | -19.56%-18.85M | -181.85%-8.56M | -89.02%-15.77M | -93.75%-3.04M | 22.99%-8.34M |
| Purchase of intangible assets | 60.71%-8.36M | -156,230.43%-35.96M | -92,391.30%-21.27M | ---23K | ---23K | ---- | ---- | 95.69%-11K | 87.91%-11K | 89.91%-255K |
| Sale of subsidiaries | --3.72M | ---174K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---24.59M | ---- | ---- |
| Recovery of cash from investments | 22,134.02%21.57M | 5.78%3.22M | 1,516.67%97K | -87.91%3.04M | -99.95%6K | -25.42%25.17M | -36.92%12.09M | 26.56%33.75M | 95,740.00%19.17M | -31.70%26.66M |
| Cash on investment | -236.57%-17M | -16.67%-3.5M | 77.04%-5.05M | 88.01%-3M | -83.03%-22M | 32.35%-25.03M | 38.36%-12.02M | -145.03%-37M | -267.92%-19.5M | 72.79%-15.1M |
| Other items in the investment business | ---- | 142.38%8.48M | --3.5M | ---20M | ---- | ---- | ---- | ---- | ---- | 89.31%-807K |
| Net cash from investment operations | 62.96%-1.23M | 51.44%-12.7M | 88.98%-3.31M | -4,784.77%-26.14M | -201.69%-30.02M | 100.68%558K | 195.78%29.52M | -518.27%-82.45M | -68.99%-30.82M | 64.08%-13.34M |
| Net cash before financing | 503.64%5.1M | 63.09%-6.69M | 94.51%-1.26M | -955.45%-18.12M | -179.08%-23.04M | 97.98%-1.72M | 162.46%29.13M | -10,430.66%-84.92M | -69.73%-46.64M | 104.08%822K |
| Cash flow from financing activities | ||||||||||
| New borrowing | -5.56%17M | 68.29%32.8M | 9.16%18M | 282.16%19.49M | 685.24%16.49M | -74.50%5.1M | -79.00%2.1M | 24.56%20M | 24.12%10M | 131.10%16.06M |
| Refund | -23.67%-12.37M | -9.48%-19.15M | 3.75%-10M | 12.99%-17.49M | 48.31%-10.39M | -54.62%-20.1M | -101.00%-20.1M | -29.94%-13M | ---10M | 26.43%-10.01M |
| Issuing shares | ---- | --18.7M | --18.7M | ---- | ---- | ---- | ---- | -89.87%9.45M | --9.45M | 16.48%93.29M |
| Interest paid - financing | 18.55%-325K | -38.00%-483K | -152.53%-399K | -45.83%-350K | 20.60%-158K | 63.58%-240K | 38.58%-199K | -40.21%-659K | -72.34%-324K | -1,282.35%-470K |
| Absorb investment income | --851K | --960K | ---- | ---- | ---- | ---- | ---- | --3.83M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---1.46M | ---1.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | ---557K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---245K |
| Net cash from financing operations | -91.01%1.77M | 285.35%19.43M | 1,322.25%19.68M | 59.14%-10.48M | 106.22%1.38M | -314.28%-25.65M | -380.60%-22.24M | -87.08%11.97M | 42.50%7.93M | 88.35%92.67M |
| Effect of rate | -108.73%-11K | -66.33%201K | -79.71%126K | -78.60%597K | -59.20%621K | 244.11%2.79M | 244.54%1.52M | -491.11%-1.94M | -21,160.00%-1.05M | 12,275.00%495K |
| Net Cash | -62.70%6.87M | 144.54%12.74M | 185.07%18.42M | -4.52%-28.6M | -414.30%-21.65M | 62.48%-27.37M | 117.80%6.89M | -178.02%-72.95M | -76.64%-38.71M | 221.82%93.49M |
| Begining period cash | 81.23%28.87M | -63.74%15.93M | -63.74%15.93M | -35.87%43.94M | -35.87%43.94M | -52.22%68.52M | -52.22%68.52M | 190.22%143.4M | 190.22%143.4M | 142.74%49.41M |
| Cash at the end | 3.64%35.73M | 81.23%28.87M | 50.51%34.48M | -63.74%15.93M | -70.22%22.91M | -35.87%43.94M | -25.77%76.93M | -52.22%68.52M | 276.86%103.63M | 190.22%143.4M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --121.72M | ---- | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -23.40%121.72M | ---- | --158.9M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.